Journal of Alzheimer's Disease

Startpagina
Nederland
Amsterdam
Journal of Alzheimer's Disease

An international multidisciplinary journal The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor.

JAD is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease. Editor-in-Chief
George Perry, PhD
University of Texas at San Antonio
USA
Tel: +1.210.458.8660
Fax:+1.210.458.5658
Email: george.perry@utsa.edu
ORCID iD: 0000-0002-6547-0172

To view the full list of the Editorial Board, please visit: http://j-alz.com/board. JAD is a member of the Neuroscience Peer Review Consortium (http://nprc.incf.org). The Consortium is an alliance of neuroscience journals that have agreed to accept manuscript reviews from each other. Abstracting/Indexing

Biological Abstracts
BIOSIS Previews
CAB Abstracts
CAB Health
Chemical Abstracts Service (CAS)
CSA Biological Sciences
CSA Illumina
CSA Illustrata Natural Sciences
CSA Neurosciences Abstracts
e-psyche database
EBSCO database
Embase
EMCare
Index Copernicus
Index Medicus
Journal Citation Reports/Science Edition
MEDLINE
Neuroscience Citation Index
Prous Science Integrity
PsycInfo
PubMed
PubsHub
Science Citation Index Expanded (SciSearch)
Scopus

Audience

JAD's targeted audience is comprised of basic science researchers and clinicians in the areas of Alzheimer's disease and related disorders.

27/03/2026

In a large variety of genetic studies, probabilistic inferences are made based on information available in population databases. The accuracy of the estimates based on population samples are highly dependent on the number of chromosomes being

27/03/2026

Researchers are urging more study into whether a surgical procedure called LVA may be repurposed as a potential Alzheimer's disease treatment.

26/03/2026

As part of the Labroots Neuroscience Virtual Event Series, this webinar will explore the growing recognition of co-pathologies in Alzheimer’s disease and related dementias and the importance of measuring complex, overlapping protein signatures.

26/03/2026

Minimally invasive olfactory brush biopsy flags biological signals of Alzheimer’s disease years before memory loss occurs.

25/03/2026

Plasma eMTBR-tau243 also could help identify people with high tau burden

25/03/2026

Here are 10 positive changes that you can make to lower your risk for cognitive decline and improve your overall health, according to the Alzheimer's Association.

25/03/2026

Cystitis, bacterial disease tied to higher dementia risk independently of co-existing conditions

25/03/2026

Microstructural EEG features may offer a scalable tool for early dementia detection

25/03/2026

Nearly 7 million Americans are living with Alzheimer’s, but researchers say millions more likely have symptoms but no formal diagnosis.

24/03/2026

Doors open at 9:00 am.

24/03/2026

Blood Tests for Alzheimer’s Disease and dementia: a caregiver’s guide Dr. Koppel will give an overview of the available and emerging blood tests being employed in clinical trials that are now […]

23/03/2026

What causes chronic illness? Drug companies are very good at treating symptoms...but a surprising number of serious chronic conditions are caused by pathogen...

Adres

Nieuwe Hemweg 6B
Amsterdam
1013BG

Telefoon

+31 20 688 3355

Website

http://j-alz.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Journal of Alzheimer's Disease nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.